Tiziana Life Sciences
TLSA
30 hedge funds and large institutions have $1.78M invested in Tiziana Life Sciences in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
53% more capital invested
Capital invested by funds: $1.16M → $1.78M (+$620K)
15% more funds holding
Funds holding: 26 → 30 (+4)
0.98% more ownership
Funds ownership: 0.9% → 1.88% (+0.98%)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
+$917K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$105K |
| 3 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$80.2K |
| 4 |
ZF
Zhang Financial
Portage,
Michigan
|
+$13.6K |
| 5 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
-$309K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$51.5K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$31.8K |
| 4 |
PTP
Platform Technology Partners
New York
|
-$27.6K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$10.1K |
TLSA Hedge Fund Activity: Q3 2024 in Review
30 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2024, worth a combined $1.78M — up 53% from $1.16M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TLSA positions and 7 closed out — a net gain of 4 holders — while 2 added to existing stakes and 7 trimmed.
The largest buyer was Sanctuary Advisors, opening a new position worth an estimated $917K. The largest seller was AlphaMark Advisors, exiting entirely with an estimated $309K sold.
- 30 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2024, up from 26 in Q2 2024.
- Funds reported $1.78M of Tiziana Life Sciences stock for Q3 2024, up 53% quarter-over-quarter.
- 11 funds opened new Tiziana Life Sciences positions in Q3 2024 and 7 closed out, a net change of +4 holders.
- The largest Tiziana Life Sciences buyer in Q3 2024 was Sanctuary Advisors, an estimated $917K added.
- The largest Tiziana Life Sciences seller in Q3 2024 was AlphaMark Advisors, an estimated $309K sold.
Based on aggregated 13F filings for Q3 2024.